Search Results

signaling and the AMPK and TOR pathways, and those that alter oxidative homeostasis and severe and/or chronic

grandiflora against Candida auris FKBP12 Development and therapeutic perspectives of CXCR4 antagonists for disease Trevena Announces Preclinical TRV045 Data Providing Insight Into Novel Mechanism of Analgesic Effect in Chronic

Recent evidence indicates that GPR15 may be associated with modulation of the chronic inflammatory response

Morphine is one of the most widely used and proven analgesic for the treatment of severe acute or chronic Complex Persistent Opioid Dependence-an Opioid-induced Chronic Pain Syndrome.

substitutions and recurrent gene loss in sauropsids Noval insights and therapeutic strategies for tumor-induced kidney

ion transients evoked by cell poking independently of released autocrine ATP in Madin-Darby canine kidney

GPCR Function Interplay of Cholesterol and Actin in Neurotransmitter GPCR Signaling: Insights from Chronic

Single cell G-protein coupled receptor profiling of Transcription factor 21 expressing activated kidney

Butyrate induces STAT3/HIF-1α/IL-22 signaling via GPCR and HDAC3 inhibition to activate autophagy in head kidney

Minor Effects on Cardiac Hypertrophy Single cell G-protein coupled receptor profiling of activated kidney

high maternal mortality, is a risk factor highly associated with maternal and offspring cardiovascular disease Obesity, immunological diseases and endocrine metabolic diseases are high-risk factors for the development them, the secretin/adhesion (Class B) G protein-coupled receptors are essential drug targets for human diseases , such as endocrine diseases and cardiometabolic diseases.

Alexander Hauser, Caroline Gorvin et al. for their research on GPCR gene variants and human genetic disease of glycosaminoglycans in GPCR signaling G protein-coupled receptor-mediated autophagy in health and disease organelles Reviews, GPCRs, and more G protein-coupled receptor (GPCR) gene variants and human genetic disease Heptares Doses First Subject in Phase 1 Trial with HTL0033744, an EP4 Agonist for Inflammatory Bowel Disease Ownership from GSK of HTL0027477, a Clinic-ready, First-in-Class Oral GPR35 Agonist for Inflammatory Bowel Disease

monoclonal antibodies for the treatment of cancer, infections, metabolic disorders or inflammatory diseases Recently, functional autoantibodies targeting GPCRs have been associated with various disease-specific is to bring together the current knowledge on the role of autoantibodies targeting GPCRs in various diseases , such as cardiovascular diseases, renal diseases, autoimmune diseases such as systemic sclerosis or

insights are made into the role of neuropeptides and their immunomodulatory functions in the healthy and diseased neuropeptides, receptor isoform-specific signaling events, and the inflammatory microenvironment in disease an increase in studies that have begun modulating neuropeptide activity for the treatment of corneal diseases focuses on the role of neuropeptides in maintaining the homeostasis of the ocular surface, alterations in disease

GRK2/β-arrestin2 play multiple roles in the pathological mechanisms of a wide range of diseases including heart failure, cancer, and inflammatory diseases. cell function and focuses on the pathological implications of GRK2/β-arrestin2 in various inflammatory diseases

Aberrant EBI2 signaling is implicated in inflammatory bowel disease, sclerosis, and infectious disease oxysterol ligand and will facilitate the development of therapeutic approaches that target EBI2-linked diseases

Are Optimal Regulators of Complex Biological Systems and Orchestrate the Interface between Health and Disease GPCRs arguably represent the most effective current therapeutic targets for a plethora of diseases. The molecular diversity of GPCR signaling systems is likely to be closely associated with disease-associated complexity and compartmentalization, thus enabling a nuanced GPCR-based capacity to interdict multiple disease cellular activities implicates them as key controllers of the functional balance between health and disease

The activation of mTOR complex 1 (mTORC1) is typically observed in human disease and continues to be Understanding the upstream regulators of mTORC1 will provide a crucial link to targeting mTORC1 hyperactivated diseases Statement mTORC1 is a master regulator of many cellular processes and is often hyperactivated in human disease molecular underpinnings of these pathways will undoubtedly be promising to the mTORC1 field and human disease

dysfunction in the MOR-SNARE complex interaction can lead to various neurological disorders, such as chronic

Nichola J Smith's investigation: Gene expression of TAS1R taste receptors for cardiometabolic disease Taste Gene expression analyses of TAS1R taste receptors relevant to the treatment of cardiometabolic disease GPCRs in Neuroscience Quinpirole ameliorates nigral dopaminergic neuron damage in Parkinson's disease development GPCRs in Oncology and Immunology GPCRs and fibroblast heterogeneity in fibroblast-associated diseases

Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine Receptor CXCR3 for Autoimmune Diseases seven-transmembrane G-protein-coupled receptor (GPCR) involved in various pathologies, in particular autoimmune diseases

s Phase 1 study of CRN04894, the company’s investigational candidate for the treatment of Cushing’s disease both serum cortisol levels and 24-hour urine free cortisol excretion in the presence of sustained, disease-like

regulation of beige adipocyte formation: Implications for obesity and metabolic health GPCRs in Neuroscience Chronic

coupled receptors (GPCRs) for galanin have been discovered, which is the focus of efforts to treat diseases including Alzheimer’s disease, anxiety, and addiction.

Matthew Eddy, et al. for their investigation on Interaction Networks within Disease-Associated GαS Variants receptor endocytosis generates spatiotemporal bias in β-arrestin signaling Interaction Networks within Disease-Associated Industry News Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases

September 2022 "Systemic sclerosis (SSc) is a systemic autoimmune disease with the key features of inflammation Extracellular vesicles are another novel player to possess disease processes.

mechanistic computational approach that couples drug pharmacokinetics/pharmacodynamics and the course of disease It has begun to play important roles in drug development for complex diseases such as cancer, including

international leaders in GPCRs pharmacology, immunology, drug discovery and development for auto-immune diseases